HomePhysiciansBarry Jay Riskin, MD

Barry Jay Riskin, MD

Philosophy of Care

Neurological disease can create complications and uncertainty for patients and their families. For these reasons, it is important to connect with a physician who considers the challenges that impact all care givers as well as the patient. I strive to provide warm, compassionate, and attentive care throughout the treatment process and treat my patients and their families with respect and patience. My goal is to explain, guide, and work with patients so they can best understand, overcome, and cope with their illness. I want patients to know that I listen, care and treat them as unique individuals.

  • General

    SPECIALTIES

    • Neurology
    • Years in Practice: 26


    PATIENTS SEEN
    Accepts adults


    LANGUAGES

    • English


    MEDICAL INTERESTS
    Multiple sclerosis (I am designated as an MS Partner in Care through the National Multiple Sclerosis Society), neuromuscular disease, dementia and Parkinson's disease


    PERSONAL INTERESTS
    Exercise, travel, cooking, gardening


  • Education

    EDUCATION
    School Rush University Medical College
    Graduation Date 06/1988
    Degree Medical Doctor

    INTERNSHIPS
    School Northwestern University

    RESIDENCY
    School Rush Presbyterian St. Luke's Medical Center
    Title Residency in Neurology

    FELLOWSHIPS
    School Rush Presbyterian St. Luke's Medical Center
    Specialty Epilepsy/EEG

  • Procedures

    Neurology
  • Memberships

    • American Academy of Neurology
    • American Epilepsy Society
    • American Medical Society
    • Illinois Medical Society
    • American Heart Association
    • Chicago Neurological Society
    • International Society of Hypertension
  • Awards and Accolades

    Name Member of Advisory Health Care Committee (National Multiple Sclerosis Society, Greater Illinois)
    Date 01/2017

    Name Physician of the Year, Christie Clinic, Nominee
    Date 01/2016

    Name Physician of the Year, Provena Covenant Medical Center, Nominee
    Date 06/2013

    Name Physician of the Year, Christie Clinic, Nominee
    Date 01/2013

    Name Physician of the Year, Provena Covenant Medical Center, Nominee
    Date 06/2012

    Name Physician of the Year, Christie Clinic, Nominee
    Date 01/2012

    Name Guardian Angel, Provena Covenant Medical Center
    Date 11/2011

    Name Physician of the Year, Provena Covenant Medical Center, Nominee
    Date 06/2011

    Name Physician of the Year, Christie Clinic, Nominee
    Date 01/2011

    Name Guardian Angel, Provena Covenant Medical Center
    Date 11/2010

    Name Physician of the Year, Christie Clinic, Nominee
    Date 01/2010

  • Research & Clinical Trials

    RESEARCH

    • Co-investigator, Accuracy of StepWatch and ActiGraph accelerometers among persons with multiple sclerosis, Acorda Therapeutics, R.W. Motl (PI) with L.A. Pilutti (Co-I), 2012-2014
    • Co-investigator, Clinical importance of steps/day among persons with multiple sclerosis, Acorda Therapeutics, R.W. Motl (PI) with L.A. Pilutti (Co-I), 2012-2014
    • Co-investigator, Coordinated Multiple Sclerosis Exercise Toolkit (Project COMPLETE), National Multiple Sclerosis Society, Project VIEWS), National Multiple Sclerosis Society, R.W. Motl (PI) with Y.C. Learmonth, C.Y. Chiu, & I. Molina 10/1/2015 - 9
    • Co-investigator, Development and Evaluation of Cardiorespiratory and Muscular Fitness Testing Protocols in Persons with Multiple Sclerosis and Severe Disability, University of Illinois, 2012-Present
    • Co-investigator, Effect of UVB phototherapy on serum vitamin D in persons with MS, R.W. Motl, et al, 2014-Present
    • Co-investigator, Effects of dalfampridine on cognition in multiple sclerosis, Acorda Therapeutics, R.H.B. Benedict (PI) with R.W. Motl (Co-I), 2014-2015
    • Co-investigator, Imaging Dementia — Evidence for Amyloid Scanning (IDEAS), 2015-Present
    • Co-investigator, Protocol I5Q-MC-CGAH, A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients with Episodic Migraine, EVOLVE-2 Study, 2015- Present
    • Co-investigator, Protocol I5Q-MC-CGAI A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients with Chronic Migraine, REGAIN Study, 2015-Present
    • Co-investigator, Selective Brain Cooling in Traumatic Brain Injury and Vascular Insults in Rats, University of Illinois, 2012-Present
    • Co-Investigator, Trial of ORG 10172 in Acute Treatment of Stroke (TOAST), 1991-1993
    • Co-investigator, Views and ideas on exercise among people with multiple sclerosis (Project VIEWS), National Multiple Sclerosis Society, R.W. Motl (PI) with Y.C. Learmonth, C.Y. Chiu, & I. Molina (Co-Is), 2014-2015
    • Principal Investigator, African American Antiplatelet Stroke Prevention Study (AAASPS), St. Francis Hospital, 1995-1998
    • Principal Investigator, Correlation of Dose and Serum Drug Level of Methohexital with EEG Changes During Methohexital Suppression Test, 1992-1993
    • Site Coordinator, A Dose-Response Study of Intravenous Lorazepam in the Treatment of Status Epilepticus, 1992-1993
    • STRATIFY 2, Principal Site Investigator, JCVAntibody Program in Patients with Relapsing Multiple Sclerosis Receiving or Considering Treatment with Tysabri, 2010-Present
    • STRIVE, Principal Site Investigator, A Multicenter, Observational, Open-Labe, Single-Arm Study of Tysabri in Early Relapsing-Remitting Multiple Sclerosis in Anti-JCV Antibody Negative Patients, 2012-Present


Receive more health tips and DMG news right in your inbox!
Sign up for the Live Life Well newsletter